After Lightning-Paced Tier-1 Sellout, ClinTex’s CTi Token Lists on KuCoin Today

Bitcoin Press Release: ClinTex is all set to fulfil its promise of reducing cost and time wastage in the medical trials industry, with its CTi token available for public trading on KuCoin on Wednesday.

 

30th November 2020, London, United Kingdom: Using the combination of blockchain, artificial intelligence and smart contracts, ClinTex is an innovative medical trial platform that will usher in an era of data sharing, analytics and management in pharmaceutical development that will revolutionize the current industry. The aim: Eliminate issues that cause time and resources to be wasted and remove duplication of efforts.

 

Sharing is Caring

The pharmaceuticals industry is lucrative – an innovative medicine that can tackle a disease is worth billions in sales. However, the industry is littered with high barriers to entry and unfathomable lead times for products. Compounding these problems are the tough trial stages before drugs are approved for use. To offset this huge cost, the pharma industry simply passes on the cost to the public, with the sick paying huge amounts of money for their health. And in ClinTex’s view, this is unacceptable.

 

ClinTex is leveraging blockchain technology to herald a new age in medical trial data sharing that is secure, efficient and open. Their Clinical Trials Intelligence (CTi) platform utilizes data analytics combined with blockchain technology to address the major inefficiencies in clinical trials. Through this, the estimated $350 billion spent yearly on new medication development can be significantly reduced.

 

The CTi Platform will also enable better collaboration across the pharmaceutical industry. Currently, there are almost 3,000 studies ongoing that are evaluating Covid-19 treatments and vaccines, but most are working in isolation. Using blockchain technology, CTi will finally provide a way for Big Pharma, small Biotech, academia and  independent researchers to collaborate and share key data, allowing for faster clinical trials and less clinical trial failures.. This will support ClinTex’s vision of facilitating the delivery of new medicines Faster, Safer and Cheaper.

 

CTi Listing

Powering the ClinTex’s mission of serving humanity is its CTi token. The firm originally had an IEO in the plans, but the immense interest by participants meant ClinTex was ready to go to market with CTi much quicker. Purchased at an incredible pace, the first round completely sold out and the second round also saw unprecedented demand. ClinTex decided not to run additional, unnecessary rounds of the sale.

 

CTi has just been listed on KuCoin today, Monday 30th November, 2020 and publicly tradable in 2 days on Wednesday 2nd December, 2020. KuCoin stands amongst the top ten crypto exchanges and its high volume of trading means the token will be in the reach of hundreds of thousands of investors and individuals who share the ClinTex dream. With over 30,000 new clinical trials registered every year, and over 250,000 clinical trials ongoing at any one time, the market potential for CTi is huge. This market opportunity, coupled with ClinTex’s innovative platform, is likely to drive  significant demand for the token in the short term, with longer term sustainable token growth being driven by the roll-out of the platform in 2021. 

 

Open, Yet Secure

ClinTex offers a seamless experience of sharing medical data, but respects intellectual property at the same time. A recent report by The Guardian revealed that state sponsored hackers are constantly attempting to hack into the servers of pharma companies engaged in COVID-19 vaccine development. This is the very reason ClinTex uses blockchain. Smart contracts assure the information is released to the only right party, leading to a trustless environment.

 

Expert Opinion

Combined, the ClinTex team has over 50 years of experience in the pharma industry, with vast connections in the clinical trial sector. ClinTex is also all set to roll out its working platform in 2021. With the platform launched next year, the true power of medical trials and blockchain will be unleashed, bringing pharmacists, doctors, researchers and others under one roof, working in cohesion to make medications easier to develop and cost effective for the world. One world, one mankind, a global health benefit.

 

Join the medical revolution and trade CTi today on KuCoin!

 

Connect with ClinTex on Telegram: https://t.me/ClinTexCTi 

Join ClinTex on Twitter: https://twitter.com/ClinTexCTi 

Check up what ClinTex is up to on Medium: https://medium.com/@clintexcti 

 

About KuCoin

KuCoin is a global cryptocurrency exchange for numerous digital assets and cryptocurrencies. Launched in September 2017, KuCoin has grown into one of the most popular crypto exchanges and already has over 5 million registered users across 207 countries and regions around the world. One out of every four crypto holders in the world is with KuCoin.

 

Media Contact Details 

Contact Name: Sean Flanagan

Contact Email: info@clintex.io

 

ClinTex is the source of this content. This press release is for informational purposes only. The information does not constitute investment advice or an offer to invest. Virtual currency is not legal tender, is not backed by the government, and accounts and value balances are not subject to consumer protections.

 

About Bitcoin PR Buzz: Bitcoin PR Buzz has been proudly serving the crypto press release distribution needs of blockchain start-ups for over 8 years. Get your Bitcoin Press Release Distribution today.

 

The post After Lightning-Paced Tier-1 Sellout, ClinTex’s CTi Token Lists on KuCoin Today appeared first on Bitcoin PR Buzz.

Bitcoin PR Buzz – Massive Exposure For Bitcoin Services, Projects, and Merchants

Source: BPRB Feed

In the Age of Coronavirus, the Medical Trials Market Could Offer Better Returns than DeFi

DeFi action within blockchain has been one of 2020’s most unexpected twists of fate. The start of the year brought unprecedented uncertainty, recession, and fear to markets far and wide, on a global scale. But good things come to those who wait, and Blockchain’s revival in late 2020 seems to be the silver lining all of us were praying for.

And DeFi itself feels like Blockchain’s calling – a realisation of the original mission to provide a decentralised medium of transfer, meeting with the needs of an increasingly technological and financially-savvy society. That’s why interest has boomed, and we’re seeing some truly groundbreaking returns – A quick look at top providers shows that the heralded rates of 6-7% annual returns of yesteryear are a thing of the past. 

 

With rates creeping up over 10% for “safe” investment classes, it’s not uncommon to see over 50% returns touted for less reputable asset classes and investment pools. What’s not surprising then, is that new investors and experienced alike are being drawn into malicious and bad-actor schemes. Not to mention, most DeFi projects are all but middlemen for traditional investment schemes, acting as a guarantor.

 

With the DeFi wave stabilising, and information inefficiencies ironing out, the market begins to ask – “where from here?”. It’s clear that the drawbacks of DeFi are impacting the market, and educated assessments of less-apparent opportunities are showing higher potential profits on closer inspection.

 

COVID-19: The Overlooked Opportunity

Check the news today. Did you hear a story about COVID-19? Chances are, your answer was yes. But with the hysteria over, and more rational conversations about solutions to COVID-19 beginning, we ask – Where are the opportunities? Well, it all lies in a number:

 

The cost of getting a new drug to market today, is $2,500,000,000. That’s right – Not $25 million, not even $250 million. $2.5 billion. And what’s more, up to $8,000,000 per day is lost via revenue erosion, resulting from delays of getting medicines to market. The market for medical trials and the opportunities for a smart system to reduce revenue erosion are massive.

Back to that number. 3017 is the number of clinical trials currently in process or awaiting commencement to test vaccines for COVID-19. And with government contracts awaiting worldwide for a first-out-the-door solution, the race is on. And for an industry wracked by inefficiencies like time delays, lack of collaboration between providers, the industry yearns for a solution, one which could provide extremely competitive returns even when sat next to the current industry DeFi craze.

 

CTi: The Solution to DeFi, and Capturer of the $3.5bn Market?

Luckily one startup, ClinTex, recognised the opportunity presenting itself in the clinical trials market, and decided to use blockchain and machine learning to access the untapped potential of inefficiencies in the pharmaceutical industry. 

 

ClinTex’s platform will reduce lead time for new drugs, improve cross-collaboration in the global medicines market for the betterment of humanity, vastly increase data collection and storage including immutability, and most importantly, reduce by an unfathomable amount the high cost of clinical trials in new drug development. 

 

What’s more, is that ClinTex are currently offering interested parties the opportunity to own their native token CTi through their token pre-sale at a 50% discounted rate, which will allow them access to the clinical trials ecosystem. And with such a large market to be tapped, the tokens look likely to become hot property in the wake of the COVID-19 pandemic. 

 

With all of ClinTex’s benefits, it doesn’t take a stretch of the imagination to envision how CTi could well be instrumental in bringing globally disjointed efforts together to bring forth life-saving vaccines, as well as countless other necessary medicines – Think cancer treatments, AIDS, and other “incurable” diseases. All is possible in the future of CTi.

 

To join the CTi presale today and get 50% off, visit https://www.clintex.io/presale

 

ClinTex is the sole source of this information.Virtual currency is not legal tender, is not backed by the government, and accounts and value balances are not subject to consumer protections. This press release is for informational purposes only. The information does not constitute investment advice or an offer to invest.

About Bitcoin PR Buzz: Bitcoin PR Buzz has been proudly serving the crypto press release distribution needs of blockchain start-ups for over 8 years. Get your Bitcoin Press Release Distribution today.

 

The post In the Age of Coronavirus, the Medical Trials Market Could Offer Better Returns than DeFi appeared first on Bitcoin PR Buzz.

Bitcoin PR Buzz – Massive Exposure For Bitcoin Services, Projects, and Merchants

Source: BPRB Feed